Ovarian function after adjuvant chemotherapy for breast cancer . . . . . . . . . . . . . . . . . 121 1.1. Pathophysiology of ovarian dysfunction after chemotherapy . . . . . . . . . . . . . . . . 122 1.2. Effect of age . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122 1.3. Effect of chemotherapy agent. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
No takes yet. Share an insight, caveat, or question.
Hensley et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: